Clinical Trials Logo

Clinical Trial Summary

In order to tackle the unmet needs in chronic HBV infection, a consortium of clinical partners has gathered to establish a registry for patients with hepatitis B mono- and co-infections. The partners will build up a European-wide registry to be able to stratify patients for upcoming clinical trials. Extensive analyses of virus and host-specific parameters are to be carried out from these patients. The knowledge gained thereby should contribute to a better understanding of the HBV control and enable patient stratification with regard to immunomodulatory therapies. Furthermore, hepatitis B patients are to be identified who are willing to participate in future studies to investigate immunotherapies to cure HBV infections (e.g. therapeutic vaccines).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05051098
Study type Observational [Patient Registry]
Source Hannover Medical School
Contact Petra Dörge
Phone +49511532
Email doerge.petra@mh-hannover.de
Status Recruiting
Phase
Start date May 6, 2021
Completion date December 2025

See also
  Status Clinical Trial Phase
Recruiting NCT05392387 - Treatment and Prognosis of Patients With Chronic HBV Infection
Recruiting NCT06023056 - Hepatitis B Vaccination After Neonatal Surgery
Recruiting NCT03864263 - Hepatitis B Virus Infection in Immunized Children With HBsAg-positive Parents
Completed NCT02798549 - HBV Virions Bound Proteins N/A
Recruiting NCT03695029 - Maternal Screening and Antiviral Therapy in Pregnant Women to Reduce Mother-to-infant Transmission of Hepatitis B Virus Phase 4
Completed NCT00440297 - Hepatitis B Vaccine Predialysis/Dialysis Study (V232-060) Phase 3
Terminated NCT03762681 - A Study of RO7239958 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus Infection Phase 1